MetaCap

Hemab Therapeutics (COAG) News

NASDAQ: COAGHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

39.29-0.57 (-1.43%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

COAG news summary

We found 8 recent headlines mentioning Hemab Therapeutics (COAG): 0 in the past week and 7 in the past 30 days, most often from GlobeNewswire, Nasdaq, Investing.com. For price context, COAG is down 1.43% at $39.29. The most recent story, "Hemab Therapeutics to Participate in Upcoming Investor Conferences", was published by GlobeNewswire on Nov 11, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Hemab Therapeutics headlines

Compare COAG